Literature DB >> 28736899

Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study.

Sophie E Holmes1, Irina Esterlis1, Carolyn M Mazure1, Yen Ying Lim2, David Ames3,4, Stephanie Rainey-Smith5, Chris Fowler2, Kathryn Ellis4, Ralph N Martins5,6, Olivier Salvado7, Vincent Doré7,8, Victor L Villemagne2,8, Christopher C Rowe8, Simon M Laws5,9,10, Colin L Masters2, Robert H Pietrzak1,11, Paul Maruff2,12.   

Abstract

OBJECTIVE: Depressive and anxiety symptoms are common in older adults, significantly affect quality of life, and are risk factors for Alzheimer's disease. We sought to identify the determinants of predominant trajectories of depressive and anxiety symptoms in cognitively normal older adults.
METHOD: Four hundred twenty-three older adults recruited from the general community underwent Aβ positron emission tomography imaging, apolipoprotein and brain-derived neurotrophic factor genotyping, and cognitive testing at baseline and had follow-up assessments. All participants were cognitively normal and free of clinical depression at baseline. Latent growth mixture modeling was used to identify predominant trajectories of subthreshold depressive and anxiety symptoms over 6 years. Binary logistic regression analysis was used to identify baseline predictors of symptomatic depressive and anxiety trajectories.
RESULTS: Latent growth mixture modeling revealed two predominant trajectories of depressive and anxiety symptoms: a chronically elevated trajectory and a low, stable symptom trajectory, with almost one in five participants falling into the elevated trajectory groups. Male sex (relative risk ratio (RRR) = 3.23), lower attentional function (RRR = 1.90), and carriage of the brain-derived neurotrophic factor Val66Met allele in women (RRR = 2.70) were associated with increased risk for chronically elevated depressive symptom trajectory. Carriage of the apolipoprotein epsilon 4 allele (RRR = 1.92) and lower executive function in women (RRR = 1.74) were associated with chronically elevated anxiety symptom trajectory.
CONCLUSION: Our results indicate distinct and sex-specific risk factors linked to depressive and anxiety trajectories, which may help inform risk stratification and management of these symptoms in older adults at risk for Alzheimer's disease.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28736899      PMCID: PMC5773367          DOI: 10.1002/gps.4761

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  61 in total

Review 1.  Amygdala, medial prefrontal cortex, and hippocampal function in PTSD.

Authors:  Lisa M Shin; Scott L Rauch; Roger K Pitman
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

2.  The impact of DSM-IV symptom and clinical significance criteria on the prevalence estimates of subthreshold and threshold anxiety in the older adult population.

Authors:  Sébastien Grenier; Michel Préville; Richard Boyer; Kieron O'Connor; Sarah-Gabrielle Béland; Olivier Potvin; Carol Hudon; Joëlle Brassard
Journal:  Am J Geriatr Psychiatry       Date:  2011-04       Impact factor: 4.105

3.  apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice.

Authors:  Jennifer Robertson; Justine Curley; Jeffrey Kaye; Joseph Quinn; Timothy Pfankuch; Jacob Raber
Journal:  Neurobiol Aging       Date:  2005-05       Impact factor: 4.673

4.  BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions.

Authors:  Idan Shalev; Elad Lerer; Salomon Israel; Florina Uzefovsky; Inga Gritsenko; David Mankuta; Richard P Ebstein; Marsha Kaitz
Journal:  Psychoneuroendocrinology       Date:  2008-11-05       Impact factor: 4.905

5.  Predictors of progression from mild cognitive impairment to Alzheimer disease.

Authors:  K Palmer; A K Berger; R Monastero; B Winblad; L Bäckman; L Fratiglioni
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

Review 6.  Role of neurotrophic factors in the etiology and treatment of mood disorders.

Authors:  Ronald S Duman
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 7.  Risk factors for anxiety and depression in the elderly: a review.

Authors:  Dagmar Vink; Marja J Aartsen; Robert A Schoevers
Journal:  J Affect Disord       Date:  2007-08-17       Impact factor: 4.839

8.  Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study.

Authors:  John Gallacher; Anthony Bayer; Mark Fish; Janet Pickering; Sofia Pedro; Frank Dunstan; Shah Ebrahim; Yoav Ben-Shlomo
Journal:  Psychosom Med       Date:  2009-06-24       Impact factor: 4.312

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

10.  Cognitive rehabilitation of attention and memory in depression.

Authors:  Richa Priyamvada; Rupesh Ranjan; Suprakash Chaudhury
Journal:  Ind Psychiatry J       Date:  2015 Jan-Jun
View more
  6 in total

1.  Trajectories of major depression in middle-aged and older adults: A population-based study.

Authors:  Xiaoling Xiang; Jianjia Cheng
Journal:  Int J Geriatr Psychiatry       Date:  2019-06-25       Impact factor: 3.485

2.  Trajectories of depression symptoms over time differ by APOE4 genotype in older adults with type 2 diabetes.

Authors:  Inbar Lavie; Michal Schnaider Beeri; Yuval Berman; Yonathan Schwartz; Laili Soleimani; Anthony Heymann; Ramit Ravona-Springer
Journal:  Int J Geriatr Psychiatry       Date:  2021-06-02       Impact factor: 3.485

Review 3.  Influence of BDNF Genetic Polymorphisms in the Pathophysiology of Aging-related Diseases.

Authors:  Rodrigo Urbina-Varela; María Inés Soto-Espinoza; Romina Vargas; Luis Quiñones; Andrea Del Campo
Journal:  Aging Dis       Date:  2020-12-01       Impact factor: 6.745

4.  Network Analysis of Depression, Anxiety, Posttraumatic Stress Symptoms, Insomnia, Pain, and Fatigue in Clinically Stable Older Patients With Psychiatric Disorders During the COVID-19 Outbreak.

Authors:  Wen Li; Na Zhao; Xiaona Yan; Xiuying Xu; Siyun Zou; Huan Wang; Yulong Li; Xiangdong Du; Lan Zhang; Qinge Zhang; Teris Cheung; Gabor S Ungvari; Chee H Ng; Yu-Tao Xiang
Journal:  J Geriatr Psychiatry Neurol       Date:  2022-03       Impact factor: 2.680

5.  Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment, and Alzheimer's disease dementia.

Authors:  Leonie C P Banning; Inez H G B Ramakers; Paul B Rosenberg; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos
Journal:  Int J Geriatr Psychiatry       Date:  2020-09-11       Impact factor: 3.485

6.  Effects of the Sonas Program on Anxiety and Depression in Nursing Home Residents with Dementia: A 6-Month Randomized Controlled Trial.

Authors:  Alka R Goyal; Knut Engedal; Jūratė Šaltytė Benth; Benedicte Sørensen Strøm
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2021-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.